Enhanced Datamarts (EDMs), our foundational data subscriptions, cover 22 tumor types and deliver a wide pool of clinical data sourced from electronic health records, reflecting patients’ journeys from diagnosis onward.
Our EDMs feature:
sites of care
Monitor and analyze key aspects of the patient journey
The longitudinal, de-identified datasets contain curated structured, abstracted, and derived data elements by cancer type and are refreshed monthly with 30-day recency.Download fact sheet
Derive real-world endpoints using our validated real-world outcome variables
Real-world overall survival (rwOS)
Conduct robust survival analyses for studies that may span natural history of disease to comparative effectiveness with our validated mortality variable.
Real-world progression-free survival (rwPFS)
Analyze real-world progression-related endpoints across observational RWE studies with our validated real-world progression (rwP) variable.*
*available with certain subscriptions
Generate real-world evidence across the life cycle of a drug, pre- and post-launch
Flatiron real-world data has informed key clinical development decisions, supported clinical trial data in regulatory submissions, fulfilled post-marketing commitments, and enabled market access and payer decisions.
Achieve value efficiently with our data
Flatiron Knowledge Center
Flatiron’s repository of FAQs, training content, and technical webinar series. Includes tailored content based on your subscription, release notes and data dictionaries, methodology guidance and more.
Interactive data visualizations with customizable filters to explore a variety of research questions. Cohorts can be saved and shared for rapid collaboration across teams.
A suite of R packages for statistical analysis and visualization to enable faster, consistent evidence generation scaled across your organization.